Bioequivalence of pyridostigmine bromide dispersible tablets in rabbits / 南方医科大学学报
Journal of Southern Medical University
;
(12): 1778-1780, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-333814
ABSTRACT
<p><b>OBJECTIVE</b>To compare the pharmacokinetic parameters of pyridostigmine bromide dispersible tablets and common tablets in rabbits.</p><p><b>METHODS</b>Twelve rabbits were given an oral dose (60 mg) of pyridostigmine bromide dispersible tablets or common tablets in a randomized crossover study. The plasma concentration of pyridostigmine bromide was determined by reversed-phase ion pair chromatography. The pharmacokinetic parameters were calculated using DAS2.1.1 software.</p><p><b>RESULTS</b>The pharmacokinetic parameters showed no significant differences in rabbit plasma between pyridostigmine bromide dispersible tablets and common tablets. The two tablets had a C(max) of 1.83∓0.08 mg·L(-1) and 1.68∓0.03 mg·L(-1), tmax of 2.33∓0.41 h and 2.58∓0.20 h, AUC(0-24) of 15.50∓0.62 mg·h·L(-1) and 15.14∓0.30 mg·h·L(-1), AUC(0-∞) of 15.82∓0.70 mg·h·L(-1) and 15.57∓0.32 mg·h·L(-1), respectively. The relative bioavailability F(0-24) was 102.38% and F(0-∞) was 101.61% for the dispersible tablets.</p><p><b>CONCLUSION</b>The two tablets are bioequivalent in rabbits.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Bromuro de Piridostigmina
/
Comprimidos
/
Sangre
/
Farmacocinética
/
Disponibilidad Biológica
/
Equivalencia Terapéutica
/
Administración Oral
Límite:
Animales
Idioma:
Chino
Revista:
Journal of Southern Medical University
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS